Impact of anemia on in-stent restenosis after percutaneous coronary intervention

Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huilin Hu, Shijun Wang, Guanmin Tang, Changlin Zhai, Liang Shen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/15acce96d22848db8bb7bf197bce204a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:15acce96d22848db8bb7bf197bce204a
record_format dspace
spelling oai:doaj.org-article:15acce96d22848db8bb7bf197bce204a2021-11-21T12:04:15ZImpact of anemia on in-stent restenosis after percutaneous coronary intervention10.1186/s12872-021-02355-11471-2261https://doaj.org/article/15acce96d22848db8bb7bf197bce204a2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12872-021-02355-1https://doaj.org/toc/1471-2261Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–12 months after the initial PCI were enrolled in this study. Baseline clinical and procedural characteristics were compared between the ISR and non-ISR groups, and independent predictors of ISR were determined using propensity score matching. Results The incidence of anemia was 53.5% in patients with ISR and 19.0% in those without ISR. Univariable logistic regression analyses showed that anemia (OR, 4.283; 95% CI, 1.949–9.410; P < 0.001), diabetes mellitus (OR, 2.588; 95% CI, 1.176–5.696; P = 0.018), chronic kidney disease (OR, 3.058; 95% CI, 1.289–7.252; P = 0.011), multiple stenting (OR, 2.592; 95% CI, 1.205–5.573; P = 0.015), bifurcation lesion (OR, 2.669; 95% CI, 1.236–5.763; P = 0.012), and calcification (OR, 3.529; 95% CI, 1.131–11.014; P = 0.030) were closely associated with ISR. Low-density lipoprotein cholesterol (LDL-c) levels and stent diameter were also significantly linked to ISR, as was anemia (P = 0.009) after propensity score matching. Conclusion Anemia is closely associated with post-PCI ISR, and patients with lower hemoglobin levels are at a higher risk of ISR.Huilin HuShijun WangGuanmin TangChanglin ZhaiLiang ShenBMCarticleAnemiaIn-stent restenosisPercutaneous coronary interventionDiseases of the circulatory (Cardiovascular) systemRC666-701ENBMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Anemia
In-stent restenosis
Percutaneous coronary intervention
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Anemia
In-stent restenosis
Percutaneous coronary intervention
Diseases of the circulatory (Cardiovascular) system
RC666-701
Huilin Hu
Shijun Wang
Guanmin Tang
Changlin Zhai
Liang Shen
Impact of anemia on in-stent restenosis after percutaneous coronary intervention
description Abstract Background Anemia is a common risk factor for post-percutaneous coronary intervention (PCI) adverse events; however, data on its association with in-stent restenosis (ISR) is limited. Methods 538 patients who underwent PCI between January 2017 and September 2019 and follow-up angiography 9–12 months after the initial PCI were enrolled in this study. Baseline clinical and procedural characteristics were compared between the ISR and non-ISR groups, and independent predictors of ISR were determined using propensity score matching. Results The incidence of anemia was 53.5% in patients with ISR and 19.0% in those without ISR. Univariable logistic regression analyses showed that anemia (OR, 4.283; 95% CI, 1.949–9.410; P < 0.001), diabetes mellitus (OR, 2.588; 95% CI, 1.176–5.696; P = 0.018), chronic kidney disease (OR, 3.058; 95% CI, 1.289–7.252; P = 0.011), multiple stenting (OR, 2.592; 95% CI, 1.205–5.573; P = 0.015), bifurcation lesion (OR, 2.669; 95% CI, 1.236–5.763; P = 0.012), and calcification (OR, 3.529; 95% CI, 1.131–11.014; P = 0.030) were closely associated with ISR. Low-density lipoprotein cholesterol (LDL-c) levels and stent diameter were also significantly linked to ISR, as was anemia (P = 0.009) after propensity score matching. Conclusion Anemia is closely associated with post-PCI ISR, and patients with lower hemoglobin levels are at a higher risk of ISR.
format article
author Huilin Hu
Shijun Wang
Guanmin Tang
Changlin Zhai
Liang Shen
author_facet Huilin Hu
Shijun Wang
Guanmin Tang
Changlin Zhai
Liang Shen
author_sort Huilin Hu
title Impact of anemia on in-stent restenosis after percutaneous coronary intervention
title_short Impact of anemia on in-stent restenosis after percutaneous coronary intervention
title_full Impact of anemia on in-stent restenosis after percutaneous coronary intervention
title_fullStr Impact of anemia on in-stent restenosis after percutaneous coronary intervention
title_full_unstemmed Impact of anemia on in-stent restenosis after percutaneous coronary intervention
title_sort impact of anemia on in-stent restenosis after percutaneous coronary intervention
publisher BMC
publishDate 2021
url https://doaj.org/article/15acce96d22848db8bb7bf197bce204a
work_keys_str_mv AT huilinhu impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention
AT shijunwang impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention
AT guanmintang impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention
AT changlinzhai impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention
AT liangshen impactofanemiaoninstentrestenosisafterpercutaneouscoronaryintervention
_version_ 1718419228831252480